Buffered nanoemulsion for nose to brain delivery of ziprasidone hydro- chloride: Preformulation and pharmacodynamie evaluation

Current Drug Delivery

Volumn 9, Issue 6, 2012, Pages 596-607

  Bahudar, Shiva ^a   Pathak, Kamla ^a  

^a Rajiv Academy for Pharmacy ^*  (India)

Author keywords

Diffusion coefficient; Nanoemulsion; Nasal ciliotoxicity; Pharmacodynamic evaluation; Ziprasidone hydrochloride

Indexed keywords

ZIPRASIDONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; LOCOMOTION; NANOEMULSION; NASAL CILIOTOXICITY; NONHUMAN; NOSE MUCOSA; NOSE TO BRAIN DELIVERY; OSMOLARITY; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; THERMODYNAMICS; TOXICITY; TRANSMISSION ELECTRON MICROSCOPY;

ACRYLATES; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BRAIN; CHITOSAN; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EMULSIONS; MICE; MOTOR ACTIVITY; NANOPARTICLES; NASAL MUCOSA; PIPERAZINES; RATS; SHEEP; THIAZOLES;

EID: 84870186025     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720112803529792     Document Type: Article

References (27)

1. Kumar, Y.A.; Anitha, A.; Helmanth, A.; Srinivas, S. Development of rapid UV spectroscopic method for the estimation of ziprasidone hydrochloride in bulk and formulations. Digest J. Nanomat. Biostruc., 2010, 5, 279-283.
2. Deshmukh, S.S.; Potnis, V.V.; Mahaparale, P.R.; Kasture, P.V.; Gharge, V.S. Development and evaluation of ziprasidone hydro- chloride fast disintegrating/dissolving tablets using complexation techniques. Ind. J. Pharm. Edu. Res., 2009, 43, 112-119.
3. Vyas, T.K.; Babbar, A.K.; Sharma, R.K.; Singh, S.; Mishra, A. Intranasal mucoadhesive microemulsion of clonazepam preliminary studies on brain targeting. J. Pharm. Sci., 2006, 95, 1-11
4. Khan, S.; Patil, K.; Yeole, P.; Gaikwad, R. Brain targeting studies on buspirone hydrochloride after intranasal administration of mu- coadhesive formulation in rats. J. Pharm. Pharmacol., 2009, 61, 669-675.
5. Luppi, B.; Bigucci, F.; Abruzzo, A.; Corace, G.; Cerchiara, T.; Zecchi, V. Transport of drugs from nasal cavity to the central nervous system. Eur. J. Pharm. Sci., 2009, 11, 1-18.
6. Illum, L. Nasal drug delivery: new developments and strategies. Drug Disc. Today, 2002, 7, 1184-1189.
7. Illum, L.; Hinchelife, M.; David, S.S. The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability of drugs on administration in the sheep model. Pharm. Res., 2003, 27, 1474-85.
8. Mistry, A.; Stolnic, S.; Illum, L. Nanoparticles for direct nose-to - brain delivery of drugs. Int. J. Pham., 2008, 379, 146-157.
9. Ugwoke, M.; Agu, R.; Verbeke, N.; Kinget, R. Nasal mucoadhesive drug delivery: Bachground, applications, trends and future perspectives. Adv. Drug Del. Rev., 2005, 57, 1640-1665.
10. Gavini, E.; Hegge, A.B.; Rassu, G. Nasal administration of carba- mazepine using chitosan microspheres: in-vitro/in-vivo studies. Int. J. Pharm., 2006, 307, 9-15.
11. Pires, A.; Fortuna, A.; Alves, G.; Falcao, A. Intranasal drug delivery; how, why and what for. J. Pharm. Pharm. Sci., 2009, 12, 288-311.
12. Braso, A.; Princep, M.; Schmid, M.; Tabernero, A. Perez, C.; Guglietta, A. Developmental pharmacology: behaviour assay in antipsychotic methods. Clin. Pharm., 2003, 25, 1-2.
13. Shakeel, F.; Baboota, S.; Ahuja, A.; Ali, J.; Shafiq, S. Celocoxib nanoemulsion for transdermal drug delivery: characterization and in vitro evaluation. J. Disper. Sci. Tech., 2009, 30, 834-842.
14. Kumar, M.; Mishra, A.; Pathak, K. Formulation and characterization nanoemulsion of olanzapine for intranasal delivery. PDA J. Pharm. Sci. Tech, 2009, 63, 501-511.
15. Shotton, E.; Ridgway, K. Physical Pharmaceutics, 1st ed.; Clarendon press; Oxford, 2008.
16. Sinko, P.J. Martin's Physical Pharmacy and Pharmaceutical Science, 5tü ed.; Wolters kluwer; Delhi, 2008.
17. Jain, N.K. Progress in Controlled and Novel drug delivery systems, 1st ed.; C B S Publishers, New Delhi, 2004.
18. Sonja, H.; Andrea, S.; Valenta, C. Lecithin based nanoemulsion a comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physiological behaviour and skin. Int. J. Pharm., 2009, 370, 181-186.
19. Lawrence, M.J.; Rees, G.D. Microemulsion based media as a novel drug delivery system. Adv. Drug Del. Rev., 2000, 45, 89-121.
20. Orospantosa, R.; Jarilloluna, A.; Riveraaguilac, V.; Enidsanchez, L.; Godinezvictoria, M.; Camposrodrigueze, R. Effects of restraint stress on NALT structure and nasal IgA level. Immunol. Lett., 2011, 135, 78-87.
21. Kumar, M.; Mishra, A.; Babbar, A.K.; Mishra, A.K.; Mishra, P.; Pathak, K. Intranasal nanoemulsion based brain targeting drug delivery system of resperidone. Int. J. Pharm., 2008, 358, 285-291.
22. Candance, L.G.; Pollock, G.M. Nasal drug administration: potential for targeted central nervous system delivery. J. Pharm. Sci., 2005, 94, 187-195.
23. Babu, R.J.; Sathigri, S.; Kumar, T.; Pandit, J.K. Formulation of controlled release gellan gum macro beads of amoxicillin. Curr. Drug Del., 2010, 7, 36-43.
24. Kumar, M.; Mishra, A.; Babbar, A.K.; Mishra, A.K.; Mishra, P.; Pathak, K. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting. J. Drug Target., 2008, 16, 806-814.
25. Ellenbroek, B.A.; Zhang, X.; Jin, G.Z. Effect of (-) stipolidine in animal model of schizophrenia. Acta Pharmacol. Sci., 2006, 27, 1111-1118.
26. Kumar, M.; Misra, A.; Pathak, K.; Formulation and characterization of nanoemulsion-based drug delivery system of resperidone. DrugDev. Ind. Pharm., 2009, 35, 387-395.
27. Patel, S.; Chahan, S.; Soni, H.; Babbar, A.K.; Mathur, R.; Mishra, A.K.; Sawant, K. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route. J. Drug Target, 2011, 19, 468-74.